Physician
Rheumatology
Dr. Gabor G. Illei, MD
|
|
Give Review
Gabor Illei works in the field of Rheumatology. He attended University of Pcs Medical School. He received 2 awards: "Fellow (FACR)" and "Fellow". Dr. Gabor G. Illei is a published doctor and has 100 publications published. The lastest was: 'Vasculitis associated with primary rheumatologic diseases.'
Publications
- Establishment of Functional Acinar-like Cultures from Human Salivary Glands.
- The IRF5-TNPO3 association with systemic lupus erythematosus (SLE) has two components that other autoimmune disorders variably share.
- BMP6 is associated with exocrine gland dysfunction in Sjögren's syndrome patients and mice.
- The percentage of Foxp3(+) Helios(+) T regulatory cells positively correlates with disease activity in systemic lupus erythematosus.
- miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1.
- Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
- EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.
- Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.
- Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis.
- Radiochemical estimation of serum polyamine oxidase activity in human pregnancy.
- [Immunologic relation between mother and conceptus].
- Serum polyamine-oxidase activity in spontaneous abortion.
- Serum polyamine oxidase activity in normal pregnancy.
- [Premature labor and intrauterine infection].
- [Serum alpha-fetoprotein screening tests in the prevention of closure defects (a multicenter study)].
- [Relation between symptomless inflammation of the parovarium and unsuccessful tocolysis].
- [Role of undiagnosed inflammation of the embryonic structures in the mortality of premature infants].
- [Incidence of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women and gynecologic patients and their treatment with doxycycline].
- The importance of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis infections in obstetrics and gynaecology.
- HIV transmission from female to male at improperly protected sexual intercourse.
- Incidence of Mycoplasma hominis and Ureaplasma urealyticum infection in pregnant women and gynaecological patients; the effectivity of doxycycline therapy.
- Different types of false positive anti-HIV reactions in patients on haemodialysis.
- Effect of pepsin treatment on the HIV envelope and core antigens.
- E. coli antibodies do not cause false-positivity in recombinant anti-HIV assays.
- [Etiology, pathophysiology and clinical aspect of endometriosis].
- Experience with experimental biological treatment and local gene therapy in Sjogren''s syndrome: implications for exocrine pathogenesis and treatment.
- Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides.
- Novel approaches in the treatment of lupus nephritis.
- IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis.
- Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
- Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis.
- Cyclophosphamide for the treatment of systemic lupus erythematosus.
- Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases.
- Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
- Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: implications for tubulointerstitial injury in chronic glomerulonep...
- Apheresis.
- CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.
- Why is the ANA result positive?
- Vasculitis associated with primary rheumatologic diseases.
- Rationale for interleukin-6 blockade in systemic lupus erythematosus.
- On the road to the optimal treatment of lupus nephritis: are we there yet?
- Membranous lupus nephritis.
- The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemi...
- Identification of parotid salivary biomarkers in Sjogren''s syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimension...
- Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
- Biologic treatments for systemic rheumatic diseases.
- Variant form of STAT4 is associated with primary Sjögren's syndrome.
- Cytokines in Sjögren's syndrome.
- Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patie...
- Exosomes from human saliva as a source of microRNA biomarkers.
- Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren''s syndrome.
- Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects.
- Helicobacter pylori and autoimmune diseases.
- Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus.
- Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.
- MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome.
- The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
- MicroRNAs as biomarkers in rheumatic diseases.
- Basophils and the T helper 2 environment can promote the development of lupus nephritis.
- MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.
- Cytokines in Sjogren''s syndrome: potential therapeutic targets.
- Rapid vision loss associated with fludarabine administration.
- Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren''s syndrome.
- Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation ...
- Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland.
- Development of a gene transfer-based treatment for radiation-induced salivary hypofunction.
- Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren''s syndrome.
- Pathogenesis of Sjögren's syndrome.
- Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
- Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their puri...
- Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.
- Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus.
- Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction.
- Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant.
- Urinary exosomal transcription factors, a new class of biomarkers for renal disease.
- Can quantified salivary gland scintigraphy results aid diagnosis of patients with sicca symptoms?
- The clinical impact of neuropsychiatric manifestations in early systemic lupus erythematosus.
- Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
- Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty?
- Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus.
- Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
- Abnormal differentiation of memory T cells in systemic lupus erythematosus.
- Granulocytic invasion of the central nervous system after hematopoietic stem cell transplantation for systemic lupus erythematosus.
- Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
- Effect of serotype 5 adenoviral and serotype 2 adeno- associated viral vector-mediated gene transfer to salivary glands on the composition of saliva.
- Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction.
- The role of immune ablation and stem cell transplantation in severe SLE.
- Blood stem cells as therapy for severe lupus.
- Identification and characterization of circulating human transitional B cells.
- Biomarkers in systemic lupus erythematosus.
- Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
- Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.
- Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability.
- A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic...
- Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
- Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
- Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
- A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
- Monocyte response to Th1 stimulation and effector function toward human mesangial cells are not impaired in patients with lupus nephritis.
Schools
University of Pecs Medical School
SUNY Stonybrook
National Institute Health
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow (FACR)
- Fellow
Education
-
National Institutes of Health Clinical Center -
University of Pécs Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Mark J. Borigini, MD |
|
|
Dr. F Xavier Valencia, MD |
|
|
Dr. Anu Sharma, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Davey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angelique N. Collamer, MD |
|
|
Dr. Barbara B. Mittleman, MD |
|
|
Dr. William W. Mullins, MD
This Doctor is OpenDoctor Recommended.
|